Neuberger Berman Group LLC Xencor Inc Transaction History

Neuberger Berman Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $198,890 - $247,589	8,023 Added 5.83%	145,641 $3.79 Million
Q3 2022 Nov 15, 2022	SELL	$24.62 - $32.44 $29,371 - $38,700	-1,193 Reduced 0.86%	137,618 $3.58 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $2,664 - $3,916	135 Added 0.1%	138,811 $3.8 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $167,923 - $262,019	6,294 Added 4.75%	138,676 $3.7 Million
Q4 2021 Feb 11, 2022	BUY	$33.67 - $43.44 $2.59 Million - $3.34 Million	76,779 Added 138.08%	132,382 $5.25 Million
Q3 2021 Nov 12, 2021	BUY	$30.65 - $35.68 $1.7 Million - $1.98 Million	55,603 New	55,603 $1.82 Million

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.